Medtronic PLC (MDT)
NYSE
Year End April 25 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 4.036 | 3.247 | 5.115 | 5.31 | 3.924 | 5.475 | 4.131 | 4.065 |
Return on Equity (%) | 7.861 | 6.132 | 9.167 | 9.475 | 7.038 | 9.66 | 7.2 | 7.204 |
Return on Invested Capital (%) | 8.446 | 6.394 | 9.758 | 9.978 | 8.015 | 9.886 | 7.89 | 7.931 |
Operating Margin (%) | 19.172 | 22.772 | 21.733 | 17.802 | 16.004 | 19.157 | 19.214 | 17.17 |
Net Profit Margin (%) | 13.558 | 10.363 | 15.155 | 16.563 | 11.973 | 15.903 | 12.034 | 11.361 |
Book Value Per Share | -8.402 | -7.712 | -7.688 | -5.989 | -6.02 | -2.536 | -3.461 | -2.855 |
Earnings Per Share | 2.941 | 2.292 | 3.454 | 3.571 | 2.68 | 3.787 | 2.825 | 2.769 |
Cash Per Share | 3.627 | 2.709 | 3.277 | 3.087 | 2.671 | 2.791 | 1.16 | 0.967 |
Working Capital Per Share | 7.779 | 9.523 | 10.066 | 8.698 | 10.435 | 8.014 | 9.488 | 8.393 |
Operating Profit Per Share | 15.595 | 16.553 | 16.631 | 15.209 | 15.276 | 16.919 | 16.287 | 16.645 |
EBIT Per Share | 3.361 | 4.191 | 3.876 | 3.024 | 2.895 | 4.146 | 4.032 | 3.644 |
EBITDA Per Share | 3.361 | 4.191 | 3.876 | 3.024 | 2.895 | 4.146 | 4.032 | 3.644 |
Free Cash Flow Per Share | 3.462 | 2.97 | 4.325 | 4.648 | 3.998 | 5.323 | 4.612 | 4.732 |
Year End April 25 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.37B | 1.35B | 1.34B | 1.34B | 1.35B | 1.33B | N/A | N/A |
Year End April 25 2024 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 1.33B | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | 17.463 | N/A | N/A | N/A | 18.13 | N/A |
Net Profit Margin (%) | N/A | N/A | 10.27 | N/A | N/A | N/A | 13.165 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 103.9B |
Price to Earnings Ratio | 28.39 |
Price to Sales Ratio | 3.23 |
Price to Cash Ratio | 81.29 |
Price to Book Ratio | 2.07 |
Dividend Yield | 339.11% |
Shares Outstanding | 1.28B |
Average Volume (1 week) | 7.93M |
Average Volume (1 Month) | 6.28M |
52 Week Change | -0.74% |
52 Week High | 92.6799 |
52 Week Low | 75.96 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.